Total Payments
$130,620
2024 Payments
$8,376
Companies
30
Transactions
301
Medicare Patients
3,036
Medicare Billing
$720,879
Payment Breakdown by Category
Other$92,985 (71.2%)
Consulting$22,204 (17.0%)
Travel$7,522 (5.8%)
Food & Beverage$7,256 (5.6%)
Research$569.00 (0.4%)
Education$84.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $49,585 | 26 | 38.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $43,400 | 14 | 33.2% |
| Consulting Fee | $22,204 | 4 | 17.0% |
| Travel and Lodging | $7,522 | 47 | 5.8% |
| Food and Beverage | $7,256 | 208 | 5.6% |
| Unspecified | $569.00 | 1 | 0.4% |
| Education | $84.00 | 1 | 0.1% |
Payments by Type
General
$130,051
300 transactions
Research
$569.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Valeant Pharmaceuticals North America LLC | $31,543 | 33 | $0 (2017) |
| ABBVIE INC. | $30,629 | 71 | $0 (2024) |
| FUJIFILM Healthcare Americas Corporation | $19,526 | 4 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16,914 | 26 | $0 (2024) |
| Allergan Inc. | $12,758 | 54 | $0 (2019) |
| Phathom Pharmaceuticals, Inc. | $7,092 | 11 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $4,763 | 16 | $0 (2024) |
| Romark Laboratories, LC | $3,147 | 13 | $0 (2019) |
| Medtronic USA, Inc. | $1,827 | 16 | $0 (2020) |
| Covidien LP | $584.97 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,376 | 58 | Phathom Pharmaceuticals, Inc. ($7,092) |
| 2023 | $34,895 | 49 | FUJIFILM Healthcare Americas Corporation ($19,204) |
| 2022 | $10,599 | 29 | ABBVIE INC. ($10,055) |
| 2021 | $8,449 | 14 | AbbVie Inc. ($8,429) |
| 2020 | $1,148 | 6 | AbbVie Inc. ($1,050) |
| 2019 | $12,253 | 36 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($6,494) |
| 2018 | $17,919 | 39 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($10,254) |
| 2017 | $36,980 | 70 | Valeant Pharmaceuticals North America LLC ($31,543) |
All Payment Transactions
301 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: LIVER DISEASE | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $230.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | Cash or cash equivalent | $14.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,580.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $145.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | In-kind items and services | $225.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $91.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/18/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/15/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: LIVER DISEASE | ||||||
| 11/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: LIVER DISEASE | ||||||
| 11/11/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: VIROLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,580.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $101.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/10/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: LIVER DISEASE | ||||||
| 09/20/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $13.49 | General |
| Category: GI | ||||||
| 09/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/05/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Immunology | ||||||
| 09/04/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Immunology | ||||||
| 08/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| THE BLINK COVSBCC0549 STUDY | Covidien LP | $569.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 743 | 5,223 | $930,000 | $178,944 |
| 2022 | 22 | 763 | 5,427 | $1.0M | $178,491 |
| 2021 | 21 | 764 | 6,225 | $937,212 | $186,796 |
| 2020 | 21 | 766 | 6,532 | $886,419 | $176,649 |
Total Patients
3,036
Total Services
23,407
Medicare Billing
$720,879
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 12 | 3,901 | $136,500 | $67,353 | 49.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 153 | 153 | $275,400 | $31,198 | 11.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 44 | 417 | $41,700 | $15,076 | 36.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 46 | 237 | $35,550 | $11,341 | 31.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 53 | 54 | $81,000 | $9,162 | 11.3% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2023 | 22 | 33 | $33,000 | $6,691 | 20.3% |
| 91122 | Study of rectum sensitivity and function | Office | 2023 | 29 | 29 | $26,950 | $5,669 | 21.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 71 | 71 | $95,850 | $5,309 | 5.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 48 | 48 | $24,000 | $4,483 | 18.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $22,200 | $4,117 | 18.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 43 | 43 | $17,200 | $3,257 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 43 | $12,900 | $2,687 | 20.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 14 | 14 | $14,000 | $2,470 | 17.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $24,000 | $2,114 | 8.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 18 | 21 | $8,400 | $2,069 | 24.6% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 16 | 16 | $12,800 | $1,449 | 11.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 22 | 22 | $44,000 | $1,422 | 3.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $14,300 | $978.20 | 6.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 12 | $3,600 | $738.36 | 20.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 11 | 13 | $2,600 | $628.68 | 24.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 14 | 19 | $2,850 | $471.01 | 16.5% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 11 | 12 | $1,200 | $257.28 | 21.4% |
| J3380 | Injection, vedolizumab, 1 mg | Office | 2022 | 14 | 4,500 | $155,100 | $77,828 | 50.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 188 | 188 | $337,646 | $36,887 | 10.9% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2022 | 19 | 29 | $29,000 | $6,327 | 21.8% |
About Dr. Brian Garvin, MD
Dr. Brian Garvin, MD is a Gastroenterology healthcare provider based in Asheville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1992822746.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Garvin, MD has received a total of $130,620 in payments from pharmaceutical and medical device companies, with $8,376 received in 2024. These payments were reported across 301 transactions from 30 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($49,585).
As a Medicare-enrolled provider, Garvin has provided services to 3,036 Medicare beneficiaries, totaling 23,407 services with total Medicare billing of $720,879. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Asheville, NC
- Active Since 03/26/2007
- Last Updated 10/23/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1992822746
Products in Payments
- XIFAXAN (Drug) $46,182
- LINZESS (Drug) $36,444
- FUJIFILM (Device) $19,526
- VOQUEZNA (Drug) $7,092
- Linzess (Drug) $4,763
- CREON (Drug) $3,560
- VIBERZI (Drug) $2,968
- PLENVU (Drug) $2,171
- Alinia Tablets 500mg 30 count bottle (Drug) $2,095
- INTERSTIM (Device) $1,924
- Alinia (Drug) $1,052
- DUPIXENT (Biological) $181.73
- STELARA (Biological) $168.88
- ENTYVIO (Biological) $167.24
- IBSRELA (Drug) $144.25
- Epclusa (Drug) $121.10
- RINVOQ (Biological) $113.56
- INSPIRA (Device) $93.02
- DIFICID (Drug) $91.40
- RELISTOR (Drug) $89.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Asheville
Adam Zivony, M.d, M.D
Gastroenterology — Payments: $179,865
Gastroenterology $179,865
Jessica Fisher, M.d, M.D
Gastroenterology — Payments: $5,868
Gastroenterology $5,868
Charles Shrode, Md, MD
Gastroenterology — Payments: $5,452
Gastroenterology $5,452
Dr. William Harlan, M.d, M.D
Gastroenterology — Payments: $5,312
Gastroenterology $5,312
Dr. Michael Heacock, M.d, M.D
Gastroenterology — Payments: $4,276
Gastroenterology $4,276
Dr. David May, M.d, M.D
Gastroenterology — Payments: $3,411
Gastroenterology $3,411